Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
202.97M | 196.46M | 262.66M | 224.62M | 176.94M | 155.90M | Gross Profit |
61.91M | 59.97M | 83.69M | 71.70M | 58.83M | 49.67M | EBIT |
539.00K | 348.00K | 24.98M | 15.96M | 2.89M | -1.67M | EBITDA |
3.77M | 4.72M | 28.65M | 19.40M | 7.92M | 1.73M | Net Income Common Stockholders |
470.00K | 61.00K | 22.33M | 17.93M | 1.66M | -1.84M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
33.03M | 24.26M | 24.98M | 40.49M | 43.32M | 46.53M | Total Assets |
264.09M | 192.44M | 198.05M | 179.82M | 156.11M | 150.72M | Total Debt |
18.00M | 2.76M | 2.46M | 3.02M | 2.42M | 3.43M | Net Debt |
-15.03M | -21.50M | -22.52M | -32.47M | -40.89M | -27.11M | Total Liabilities |
112.71M | 34.49M | 38.73M | 43.97M | 34.55M | 32.06M | Stockholders Equity |
151.38M | 157.95M | 159.32M | 135.85M | 121.56M | 118.66M |
Cash Flow | Free Cash Flow | ||||
7.76M | 2.48M | -15.58M | -1.21M | -1.80M | 147.00K | Operating Cash Flow |
10.59M | 6.52M | -8.20M | 1.91M | 832.00K | 1.92M | Investing Cash Flow |
-2.82M | -4.04M | -2.18M | -8.12M | 13.37M | -9.78M | Financing Cash Flow |
-3.00M | -2.90M | 389.00K | -352.00K | -3.01M | -3.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $81.64B | 52.49 | 4.43% | 2.28% | -19.28% | -44.00% | |
67 Neutral | $1.08B | 19.05 | 10.99% | 0.44% | -6.36% | -0.89% | |
61 Neutral | $1.81B | 32.83 | 3.66% | ― | 9.41% | ― | |
60 Neutral | $138.20M | 301.24 | 0.30% | 3.08% | -10.16% | -94.32% | |
57 Neutral | $18.52B | 9.81 | -13.96% | 2.71% | 5.07% | -23.65% | |
47 Neutral | $56.54M | ― | -5.86% | ― | 31.09% | 35.51% | |
44 Neutral | $69.88M | ― | -30.42% | ― | -1.01% | -72.93% |
On January 24, 2025, Richardson Electronics announced the sale of its International Medical Equipment and Service business assets to DirectMed Imaging for $8.2 million. This strategic move aligns with Richardson’s priorities to support its growing Green Energy Solutions business and involves a 10-year supply agreement with DirectMed, simplifying Richardson’s operations and focusing on higher-growth markets.